Skip to content
Longterm Wiki
Index
Grant·X3h5lT3gXh·Record·Profile

Grant: University of Cape Town — Tuberculosis Vaccine Preclinical Development and Testing (Coefficient Giving → University of Cape Town)

Verdictconfirmed95%
1 check · 4/9/2026

Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Our claim

entire record
Name
University of Cape Town — Tuberculosis Vaccine Preclinical Development and Testing
Amount
$597,557
Currency
USD
Date
June 2024
Notes
[Scientific Research] Open Philanthropy recommended a grant of $597,557 over two years to the University of Cape Town to support preclinical development and testing of a tuberculosis (TB) vaccine, led by Dr. Thomas Scriba. The approach to the vaccine follows a 2022 study by Musvexpand[Scientific Research] Open Philanthropy recommended a grant of $597,557 over two years to the University of Cape Town to support preclinical development and testing of a tuberculosis (TB) vaccine, led by Dr. Thomas Scriba. The approach to the vaccine follows a 2022 study by Musvosvi et al. that identified four TB proteins associated with natural clearance of the infection. The proposed research aims to support preclinical analysis of these four proteins in human cell and mouse assays to evaluate their potential as vaccine candidates. This is one of three grants we’re making to support this work. This falls within our focus area of scientific research.

Source evidence

1 src · 1 check
confirmed95%deterministic-row-match · 4/9/2026
Name
University of Cape Town — Tuberculosis Vaccine Preclinical Development and Testing
Grantee
University of Cape Town
Focus Area
Scientific Research
Amount
$597,557.00
Date
June 2

NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Case № X3h5lT3gXhFiled 4/9/2026Confidence 95%
Source Check: Grant: University of Cape Town — Tuberculosis Vaccine Preclinical Development and Testing (Coefficient Giving -> University of Cape Town) | Longterm Wiki